We found that B7-H1-expressing LLC cells led to aggressive tumor growthin vivo, which was significantly inhibited by anti-B7-H1 treatment,supporting the anti-cancer efficacy of targeting B7-H1. This evidence concerns the gene CD274 and neoplasm.